Sun Pharmaceutical Industries—controlled by Indian billionaire Dilip Shanghvi—has agreed to buy U.S.-based immunotherapy and ...
16h
MT Newswires on MSNMallinckrodt, Endo Enter $6.7 Billion Merger Deal as Drug Makers Plan New US ListingMallinckrodt and Endo are set to merge in a cash-and-stock deal valued at $6.7 billion, with the drug makers set to list shares of the new firm on the New York Stock Exchange. Shareholders in Endo, ...
Since 2020, six of eight community health centers in Rhode Island have seen their revenue from the 340B Drug Discount Program ...
— Days after retaining the Nickles Group, Novo Nordisk also hired Checkmate Government Relations, the new D.C. outpost of a ...
New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.
BERLIN (Reuters) -Roche has entered an exclusive collaboration and licensing agreement with Danish obesity drug maker Zealand ...
After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight ...
Shares of Novo Nordisk A/S were getting hit hard Monday, after the maker of Ozempic and Wegovy, the diabetes and obesity treatments, revealed data showing that its new weight-loss drug candidate ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results